Nanofabrications of Erythrocyte Membrane-Coated Telmisartan Delivery System Effective for Radiosensitivity of Tumor Cells in Mice Model
Shaoqing Chen,Cheng Wang,Yanyan Meng,Pengyin Li,Yiwen Pan,Mu He,Xinye Ni
DOI: https://doi.org/10.2147/ijn.s441418
IF: 7.033
2024-02-16
International Journal of Nanomedicine
Abstract:Shaoqing Chen, 1, 2 Cheng Wang, 3 Yanyan Meng, 1– 3 Pengyin Li, 1– 3 Yiwen Pan, 1– 3 Mu He, 1, 2 Xinye Ni 1, 2 1 Department of Radiotherapy, the Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, 213003, People's Republic of China; 2 Jiangsu Province Engineering Research Center of Medical Physics, Changzhou, Jiangsu, 213003, People's Republic of China; 3 School of Pharmacy, Changzhou University, Changzhou, Jiangsu, 213164, People's Republic of China Correspondence: Xinye Ni, Email Background: Radiation stimulates the secretion of tumor stroma and induces resistance, recurrence, and metastasis of stromal-vascular tumors during radiotherapy. The proliferation and activation of tumor-associated fibroblasts (TAFs) are important reasons for the production of tumor stroma. Telmisartan (Tel) can inhibit the proliferation and activation of TAFs (resting TAFs), which may promote radiosensitization. However, Tel has a poor water solubility. Methods: In this study, self-assembled telmisartan nanoparticles (Tel NPs) were prepared by aqueous solvent diffusion method to solve the insoluble problem of Tel and achieve high drug loading of Tel. Then, erythrocyte membrane (ECM) obtained by hypotonic lysis was coated on the surface of Tel NPs (ECM/Tel) for the achievement of in vivo long circulation and tumor targeting. Immunofluorescence staining, western blot and other biological techniques were used to investigate the effect of ECM/Tel on TAFs activation inhibition (resting effect) and mechanisms involved. The multicellular spheroids (MCSs) model and mouse breast cancer cells (4T1) were constructed to investigate the effect of ECM/Tel on reducing stroma secretion, alleviating hypoxia, and the corresponding promoting radiosensitization effect in vitro. A mouse orthotopic 4T1 breast cancer model was constructed to investigate the radiosensitizing effect of ECM/Tel on inhibiting breast cancer growth and lung metastasis of breast cancer. Results: ECM/Tel showed good physiological stability and tumor-targeting ability. ECM/Tel could rest TAFs and reduce stroma secretion, alleviate hypoxia, and enhance penetration in tumor microenvironment. In addition, ECM/Tel arrested the cell cycle of 4T1 cells to the radiosensitive G2/M phase. In mouse orthotopic 4T1 breast cancer model, ECM/Tel played a superior role in radiosensitization and significantly inhibited lung metastasis of breast cancer. Conclusion: ECM/Tel showed synergistical radiosensitization effect on both the tumor microenvironment and tumor cells, which is a promising radiosensitizer in the radiotherapy of stroma-vascular tumors. Keywords: telmisartan, tumor-associated fibroblasts, tumor hypoxia, G2/M arrest, radiosensitization So far, radiotherapy is still widely recognized as one of the most effective cytotoxic therapies to combat localized tumors. It was estimated that over half of the cancer patients had received curative radiotherapy during their course of illness 1,2 and the combination of radiation therapy with other modalities, such as chemotherapy, immunotherapy, etc., has been widely explored at both experimental and clinical practices. 3,4 However, the unavoidable damage to the adjacent normal tissue upon treatment has long been considered as the "Achilles' Heel" of radiation therapy. In particular, to find the delicate balance between cure and harm, under some circumstances, radiation dose de-escalation has been applied to give compromise to the increasing side effects. 5,6 Therefore, the concept of "radiosensitization" has been proposed in recent years to strike the right balance between tumor eradication and minimizing the possible side effects. 7,8 The cytotoxicity effect of radiotherapy relies on producing reactive oxygen species (ROSs), during which O 2 is essential for ROS generation and DNA damage fixation. 9 However, many tumor tissues, especially stroma-vascular tumors, usually suffer from low oxygen levels, where O 2 content is even less than 1–2% (v/v) of normal tissues. 10 Under hypoxia, tumor cells usually require 2.5 to 3 times higher irradiation dose to achieve the same level of damage compared to that under normal O 2 conditions. 11 Most current research focused on increasing the local oxygen content of the tumor through exogenous oxygen-carrying or catalytic oxygen production agents or combined with the introduction of high atomic number materials to absorb more radiation energy and enhance the local radiation energy in cells for radi -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology